// App-Quantinova.ai

: A Novel Glycomimetic Compound (GMI-1757) with Dual Functional Antagonism to E-Selectin and Galectin-3 Demonstrates Inhibition of Thrombus Formation in an Inferior Vena Cava Model

Researchers

Presenter

  • John Peterson

Principal Investigators

  • Yusuf Vohra

  • Daniel Durant Myers

  • Silvia Locatelli-Hoops

  • Ji-Won Lee

  • Lingquan Deng

  • Theodore AG Smith

  • William E Fogler

  • John L Magnani

Medical Centers

  • GlycoMimetics Inc, Rockville, MD.

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • E-selectin

  • Galectin-3

Drug/Treatment

  • GMI1271

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved